Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7367831, 8 pages
https://doi.org/10.1155/2017/7367831
Research Article

Vitamin B-6, Independent of Homocysteine, Is a Significant Factor in Relation to Inflammatory Responses for Chronic Kidney Disease and Hemodialysis Patients

1Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan
2Division of Basic Medical Sciences, Department of Medical Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan
3Department of Life Science, Tunghai University, Taichung 40705, Taiwan
4Graduate Program in Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
5Division of Nephrology, Department of Internal Medicine, Chiayi Branch, Taichung Veterans General Hospital, Chiayi 60090, Taiwan
6Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
7Department of Nutrition, Chung Shan Medical University Hospital, Taichung 40201, Taiwan

Correspondence should be addressed to Yi-Chia Huang; wt.ude.umsc@hcy

Received 6 June 2017; Revised 11 August 2017; Accepted 20 August 2017; Published 26 September 2017

Academic Editor: Charnita M. Zeigler-Johnson

Copyright © 2017 Cheng-Hsu Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Eustace, B. Astor, P. M. Muntner, T. A. Ikizler, and J. Coresh, “Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease,” Kidney International, vol. 65, no. 3, pp. 1031–1040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Carrero and P. Stenvinkel, “Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 1, pp. S49–S55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Carrero and P. Stenvinkel, “Inflammation in end-stage renal disease-what have we learned in 10 years?” Seminars in Dialysis, vol. 23, no. 5, pp. 498–509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Miyamoto, J. J. Carrero, and P. Stenvinkel, “Inflammation as a risk factor and target for therapy in chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 6, pp. 662–668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Kotur-Stevuljevic, S. Simic-Ogrizovic, V. Dopsaj et al., “A hazardous link between malnutrition, inflammation and oxidative stress in renal patients,” Clinical Biochemistry, vol. 45, no. 15, pp. 1202–1205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. D. Imig and M. J. Ryan, “Immune and inflammatory role in renal disease,” Comprehensive Physiology, vol. 3, no. 2, pp. 957–976, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. V. Barreto, F. C. Barreto, S. Liabeuf et al., “Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease,” Kidney International, vol. 77, no. 6, pp. 550–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. L. Meuwese, P. Stenvinkel, F. W. Dekker, and J. J. Carrero, “Monitoring of inflammation in patients on dialysis: Forewarned is forearmed,” Nature Reviews Nephrology, vol. 7, no. 3, pp. 166–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. L. Meuwese, S. Snaedal, N. Halbesma et al., “Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 26, no. 4, pp. 1313–1318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. P. Coburn, R. D. Reynolds, J. D. Mahuren et al., “Elevated plasma 4-pyridoxic acid in renal insufficiency,” The American Journal of Clinical Nutrition, vol. 75, pp. 57–64, 2002. View at Google Scholar
  11. M. Mydlík and K. Derzsiová, “Vitamin B6 and oxalic acid in clinical nephrology,” Journal of Renal Nutrition, vol. 20, no. 5, pp. S95–S102, 2010. View at Publisher · View at Google Scholar
  12. M. Corken and J. Porter, “Is vitamin B 6 deficiency an under-recognized risk in patients receiving haemodialysis? A systematic review: 2000-2010,” Nephrology, vol. 16, no. 7, pp. 619–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Busch, A. Göbert, S. Franke et al., “Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease.,” Nephron. Clinical practice, vol. 114, no. 1, pp. c38–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Nand, M. Sharma, and N. Mittal, “Prevalence of hyperhomocysteinaemia in chronic kidney disease and effect of supplementation of folic acid and vitamin B12 on cardiovascular mortality,” Journal, Indian Academy of Clinical Medicine, vol. 14, no. 1, pp. 33–36, 2013. View at Google Scholar · View at Scopus
  15. A. Levi, E. Cohen, M. Levi, E. Goldberg, M. Garty, and I. Krause, “Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: a historical prospective study,” European Journal of Internal Medicine, vol. 25, no. 10, pp. 951–955, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Friso, P. F. Jacques, P. W. F. Wilson, I. H. Rosenberg, and J. Selhub, “Low circulating vitamin B6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels,” Circulation, vol. 103, no. 23, pp. 2788–2791, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Talwar, T. Quasim, D. C. McMillan, J. Kinsella, C. Williamson, and D. S. J. O'Reilly, “Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response,” Clinical Chemistry, vol. 49, no. 3, pp. 515–518, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. E.-P. Chiang, D. E. Smith, J. Selhub, G. Dallal, Y.-C. Wang, and R. Roubenoff, “Inflammation causes tissue-specific depletion of vitamin B6.,” Arthritis research & therapy, vol. 7, no. 6, pp. R1254–1262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S.-C. Huang, J. C.-C. Wei, D. J. Wu, and Y.-C. Huang, “Vitamin B6 supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis,” European Journal of Clinical Nutrition, vol. 64, no. 9, pp. 1007–1013, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Ulvik, Ø. Midttun, E. R. Pedersen, S. J. P. M. Eussen, O. Nygård, and P. M. Ueland, “Evidence for increased catabolism of vitamin B-6 during systemic inflammation,” American Journal of Clinical Nutrition, vol. 100, no. 1, pp. 250–255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Jankowska, M. Marszałł, A. Debska-Ślizień et al., “Vitamin B6 and the immunity in kidney transplant recipients,” Journal of Renal Nutrition, vol. 23, no. 1, pp. 57–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Jankowska, P. Trzonkowski, A. Dębska-Ślizień et al., “Vitamin B6 status, immune response and inflammation markers in kidney transplant recipients treated with polyclonal anti-thymocyte globulin,” Transplantation Proceedings, vol. 46, no. 8, pp. 2631–2635, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Gori, A. M. Corsi, S. Fedi et al., “A proinflammatory state is associated with hyperhomocysteinemia in the elderly,” American Journal of Clinical Nutrition, vol. 82, no. 2, pp. 335–341, 2005. View at Google Scholar · View at Scopus
  24. J. T. Wu, “Circulating homocysteine is an inflammation marker and a risk factor of life-threatening inflammatory diseases,” Journal of Biomedical and Laboratory Sciences, vol. 19, pp. 107–111, 2007. View at Google Scholar
  25. M. E. L. Oudi, Z. Aouni, C. Mazigh et al., “Homocysteine and markers of inflammation in acute coronary syndrome,” Experimental and Clinical Cardiology, vol. 15, pp. e25–e28, 2010. View at Google Scholar
  26. T. N. van den Kommer, M. G. Dik, H. C. Comijs, C. Jonker, and D. J. H. Deeg, “Homocysteine and inflammation: predictors of cognitive decline in older persons?” Neurobiology of Aging, vol. 31, no. 10, pp. 1700–1709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Mansoor, I. Seljeflot, H. Arnesen et al., “Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia,” Clinical Biochemistry, vol. 37, no. 5, pp. 408–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Li, J. Chen, Y.-S. Li, Y.-B. Feng, X. Gu, and C.-Z. Shi, “Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia,” International Journal of Cardiology, vol. 106, no. 2, pp. 285–288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Talwar, T. Quasim, D. C. McMillan, J. Kinsella, C. Williamson, and D. S. J. O'Reilly, “Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 792, no. 2, pp. 333–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Araki and Y. Sako, “Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection,” Journal of Chromatography B, vol. 422, pp. 43–52, 1987. View at Publisher · View at Google Scholar · View at Scopus
  31. Food and Nutrition Board, Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, National Academies Press, Washington, DC, USA, 1998. View at Publisher · View at Google Scholar
  32. J. Selhub, P. F. Jacques, D. Rush, I. H. Rosenberg, and P. W. F. Wilson, “Vitamin Status and intake as primary determinants of homocysteinemia in an elderly population,” JAMA: The Journal of the American Medical Association, vol. 270, no. 22, pp. 2693–2698, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. A. N. Friedman, L. G. Hunsicker, J. Selhub, and A. G. Bostom, “Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy,” Atherosclerosis, vol. 172, no. 1, pp. 121–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Paul, P. M. Ueland, and J. Selhub, “Mechanistic perspective on the relationship between pyridoxal 5'-phosphate and inflammation,” Nutrition Reviews, vol. 71, no. 4, pp. 239–244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Zhang, K. Tsuchiya, T. Kinoshita et al., “Vitamin B6 prevents IL-1β protein production by inhibiting nlrp3 inflammasome activation,” Journal of Biological Chemistry, vol. 291, no. 47, pp. 24517–24527, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. Ø. Midttun, A. Ulvik, E. R. Pedersen et al., “Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation,” Journal of Nutrition, vol. 141, no. 4, pp. 611–617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Rao, D. Guo, M. C. Perianayagam et al., “Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients,” American Journal of Kidney Diseases, vol. 45, no. 2, pp. 324–333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. M.-C. Chao, S.-L. Hu, H.-S. Hsu et al., “Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population,” Journal of Nephrology, vol. 27, no. 3, pp. 299–305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. N. Friedman, A. G. Bostom, J. Selhub, A. S. Levey, and I. H. Rosenberg, “The kidney and homocysteine metabolism,” Journal of the American Society of Nephrology, vol. 12, no. 10, pp. 2181–2189, 2001. View at Google Scholar · View at Scopus
  40. M. E. Suliman, B. Lindholm, P. Bárány, and J. Bergström, “Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease,” Clinical Chemistry and Laboratory Medicine, vol. 39, no. 8, pp. 734–738, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. H. F. Tbahriti, “Inflammatory status in chronic renal failure: the role of homocysteinemia and pro-inflammatory cytokines,” World Journal of Nephrology, vol. 2, no. 2, p. 31, 2013. View at Publisher · View at Google Scholar
  42. P. J. Kelly, J. P. Kistler, V. E. Shih et al., “Inflammation, homocysteine, and vitamin B6 status after ischemic stroke,” Stroke, vol. 35, no. 1, pp. 12–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Cianciolo, G. La Manna, L. Colì et al., “5-Methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients,” American Journal of Nephrology, vol. 28, no. 6, pp. 941–948, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Cianciolo, A. De Pascalis, L. Di Lullo, C. Ronco, C. Zannini, and G. La Manna, “Folic acid and homocysteine in chronic kidney disease and cardiovascular disease progression: which comes first?” Cardiorenal Medicine, pp. 255–266. View at Publisher · View at Google Scholar
  45. A. C. T. M. Peeters, B. E. Van Aken, H. J. Blom, P. H. Reitsma, and M. Den Heijer, “The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 1, pp. 54–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Picotte, C. G. Campbell, and W. G. Thorland, “Day-to-day variation in plasma interleukin-6 concentrations in older adults,” Cytokine, vol. 47, no. 3, pp. 162–165, 2009. View at Publisher · View at Google Scholar · View at Scopus